Translate Bio
Latest round
- Series C
Last raised
- Dec 2016
Total raised
- $129M
Investors
- 13
About Translate Bio
Translate Bio, Inc.Translate Bio, Inc. specializes in mRNA therapeutics, founded in 2011 and headquartered in Lexington, US.A.2 billion. The CEO is Rana Latif, who has a strong background in the industry.Translate Bio, Inc. focuses on mRNA therapeutics, crafting solutions aimed at treating various diseases.In 2020, Translate Bio, Inc.Translate Bio, Inc.A. to expand its product offerings in mRNA therapies, targeting new disease areas by mid-2022.2 billion will be directed towards accelerating the development of its therapeutics pipeline and expanding into international markets.
Who invested in Translate Bio
13 investors across 4 rounds
See all investors in Translate Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Translate Bio
Who invested in Translate Bio?
Translate Bio has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Translate Bio raised?
Translate Bio has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Translate Bio last raise money?
Translate Bio's most recent round on record is a Series C, in Dec 2016.
What does Translate Bio do?
Translate Bio is a biotechnology company.
Where is Translate Bio headquartered?
Translate Bio is headquartered in Lexington, US.
Which VCs invest in companies like Translate Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Translate Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Translate Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.